Commonwealth Medicine, Center for Health Policy and Research; Department of Family Medicine and Community Health; Department of Quantitative Health Sciences
Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Substance Abuse and Addiction
This presentation discusses the impact of prior authorization on Buprenorphine dose, relapse, and cost for opioid addiction treatment for Massachusetts Medicaid members.
Presented at the AcademyHealth Annual Research Meeting 2013.
Drug addiction treatment, Medicaid, buprenorphine, pharmaceutical policy, prior authorization, opioid treatment
DOI of Published Version
Commonwealth Medicine Publications
Clark RE, Baxter JD, Barton BA, Aweh G, O'Connell E, Fisher B. (2013). The Impact of Prior Authorization on Buprenorphine Dose, Relapse and Cost of Opioid Addiction Treatment. Commonwealth Medicine Publications. https://doi.org/10.13028/kwyc-1452. Retrieved from https://escholarship.umassmed.edu/commed_pubs/81